About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Read More Watch Video

Area of Focus

API

FDF

CDMO
40+

Products

86+

Countries

1500+

Customers

22%

& above CAGR since 2019

400+

Employee Strength

We have a global footprint that extends across 86 countries

APIs

FDF

Awards

Latest News

16 December 2025

Supriya Lifescience targets Rs 1,600-cr revenue in three years on capacity expansion

Read More

16 December 2025

Supriya Lifescience targets Rs 1,600-cr revenue in three years on capacity expansion

Read More

16 December 2025

Supriya Lifescience: Rs 1600 Cr Revenue Target

Read More

16 December 2025

Supriya Lifescience Targets ₹1,600-Cr Revenue in Three Years on Capacity

Read More

16 December 2025

Supriya targets Rs 1,600-cr revenue

Read More

29 November 2025

From APIs to innovation: India’s bulk drug makers ramp up CDMO bets

Read More

25 November 2025

Supriya Lifescience ramps up capacity of its Lote facility with new module E

Read More

15 November 2025

Supriya Lifescience Reports Strong Revenue Results

Read More

14 November 2025

Supriya Lifescience delivers strong Q2 FY26 performance with 20.3% year-over-year revenue growth

Read More

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.

Read More
BSE
NSE